LYNCH DANIEL received a stock award from SPRINGWORKS THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/20/2022ACC: 0001104659-22-063508
Director
Since Sep 2019
+20.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
20.14K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.82K
Price / share
—
Trade value
—
% of position
1.6%
5/19/2022
292.38K→297.20K
Total
Net shares
+4.82K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2022 | A · Award | +4.82K | — | — | 1.6% | 292.38K | 297.20K |
| Total | +4.82K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
15.32K shares
Shares
+15.32K
Strike price
35.42
Held after
15.32K
Exercisable
—
5/19/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock15.32K shares | 5/19/2022 | A · Award | +15.32K | 35.42 | — | 15.32K |